BriaCell Therapeutics Corp (TSX:BCT)
C$ 0.97 0 (0%) Market Cap: 35.10 Mil Enterprise Value: 33.90 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 35/100

Briacell Therapeutics Corp at Benzinga Global Small Cap Investor Conference (Virtual) Transcript

Dec 09, 2021 / 06:35PM GMT
Release Date Price: C$11.27 (-5.45%)
Brent Slava
Benzinga - Moderator

Ladies and gentlemen, coming up next, the chat is super hype about this next presentation and why not. Let's bring him on here. Here we have Bill Williams from BriaCell. Its ticker BCTX.

Bill, how you doing today?

Bill Williams
BriaCell Therapeutics Corp. - President & CEO

Doing great. It's great to join you at Bezinga here, Brent.

Brent Slava
Benzinga - Moderator

Yes. Like I said, the chat out in the YouTube land is absolutely excited for the presentation today. So I'll let you have at it, Bill. Take it away.

Bill Williams
BriaCell Therapeutics Corp. - President & CEO

Great. Thanks so much. Of course, we have forward-looking statements in here. Just a brief snapshot of our cap structure. We are a preclinical -- not preclinical, pre-revenue company in biotech. So a little bit different than what you were just looking at for urban-gro. But share price around $9; shares outstanding, 15.5 million or so, market cap about

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot